Specialties:

Dr. Yang is a thoracic surgeon with a special interest in minimally invasive surgery and management of pulmonary nodules. He performs these operations through small incisions to minimize discomfort and enhance recovery using the latest technology. He is experienced in management of small lung nodules (including GGO), and surgery and multidisciplinary therapy of complex thoracic tumors including pancoast tumor, locally advanced lung cancers, re-operative surgery, complicated airway tumor.

Clinical Interests: His clinical interests include multidisciplinary management of lung cancer and minimally invasive thoracic surgery. His research is focused on better understanding of early stage lung cancer and ground-glass opacity through molecular biological and clinical features.

Bio：

Dr. Yang's research looks into surgical quality and outcomes. His research has concentrated on the multidisciplinary management of  lung cancer. His scientific research includes better understanding of how tumors evolve and spread, in order to investigate new ways to treat them. He is also active in adjuvant and neoadjuvant therapy by precision medicine and immunotherapy. He holds several patents in the field of minimally invasive surgery, including a novel electric hook device that has been used by many surgeons.

Education:

2006       Visiting Fellow, in Thoracic Surgery,    European Institute of Oncology Milan, Italy

2005-2006       Visiting Fellow, in Thoracic Surgery,    Istituto Nazionale Tumori (Istituto Nazionale per lo Studio e la Cura dei Tumori) National Cancer Institute Milan, Italy

1997– 2002  MD&PHD in Oncology,  Resident, Sun Yat-Sen University, China

1989– 1994  Intern，Clinical Medicine, Central South university, China

Awards and Honors

Winner of Second Prize of National Award for Science and Technology Progress.

Winner of First Prize of Science and Technology Award of Guangdong Province.

Professional memberships

Vice Chairman of Lung Cancer Committee of Chinese Anti-Cancer AssociationCouncil member of Chinese Society of Clinical Oncology

Editorial board member of Clinical guidelines for lung cancer in China

Publications

1.Chao Zhang, Kai Yin, Si-Yang Liu, Li-Xu Yan, Jian Su, Yi-Long Wu, Xu-Chao Zhang, Wen-Zhao Zhong and Xue-Ning Yang. Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy. J Immunother Cancer. 2021 Apr;9(4):e002312. doi: 10.1136/jitc-2020-002312.

2.Hao-Yue Guo, Jun-Tao Lin, Hao-Hua Huang, Yuan Gao, Mei-Ru Yan, Ming Sun, Wei-Ping Xu, Hong-Hong Yan, Wen-Zhao Zhong, Xue-Ning Yang. Development and Validation of a 18F-FDG PET/CT-Based Clinical Prediction Model for Estimating Malignancy in Solid Pulmonary Nodules Based on a Population With High Prevalence of Malignancy. Clin Lung Cancer. 2020 Jan;21(1):47-55. https://doi.org/10.1016/j.cllc.2019.07.014

3.Jun-tao Lin, Xue-ning Yang, Wen-zhao Zhong, Ri-qiang Liao, Song Dong, Qiang Nie, Si-xian Weng, Xiao-jing Fang, Jun-yi Zheng, Yi-long Wu. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer. Eur J Cardiothorac Surg. 2016, 50(5): 914-919.doi:10.1093/ejcts/ezw109.

4.Wenzhao Zhong, Xuening Yang, Honghong Yan, Xuchao Zhang, Jian Su, Zhihong Chen, Riqiang Liao, Qiang Nie, Song Dong, Qing Zhou, Jinji Yang, Haiyan Tu, Yi-Long Wu. Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status. J Hematol Oncol. 2015; 8: 54. Published online 2015 May 17. doi: 10.1186/s13045-015-0151-3 PMCID: PMC4455050

5.Xue-Ning Yang, Ze-Rui Zhao, Wen-Zhao Zhong, Qiang Nie, Ri-Qiang Liao, Song Dong. A lobe-specific lymphadenectomy protocol for solitary pulmonary nodules in non-small cell lung cancer. Chin J Cancer Res.2015;27(6):538-544 doi: 10.3978/j.issn.1000-9604.2014.11.04

6.Xue-Ning Yang, Ling Huang, Yu Chen, She-Juan An, Xu-Chao Zhang, Ri-Qiang Liao, Jian Su, Yi-Long Wu. Single nucleotide polymorphisms of MAGE-A3 gene and its clinical implications in Chinese patients with non-small cell lung cancer (NSCLC). Chin J Cancer Res. 2015, 27(3): 301-308  (2014 IF 1.935; 2015 IF 2.201)7.Xuan Zhang, Hong-Hong Yan, Jun-Tao Lin, Ze-Hua Wu, Jia Liu, Xu-Wei Cao, Xue-Ning Yang.Comparison of three mathematical prediction models in patients with a solitary pulmonary nodule. Chin J Cancer Res.2014 Dec;26(6):647-52. doi: 10.3978/j.issn.1000-9604.2014.11.02.

8.杨学宁. T1-3N2M0非小细胞肺癌手术加化放疗相较化放疗未改善生存.循证医学.2013,13(2):129

9.杨学宁，林欢，吴一龙. 临床Ⅰ期非小细胞肺癌的选择性淋巴结清扫术.癌症进展.2010，8(6):549-553.